Zynerba Pharmaceuticals Announces Poster at the Associated Professional Sleep Societies SLEEP 2021 Annual Meeting

Zynerba Pharmaceuticals

DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced the acceptance and presentation details of a poster at SLEEP 2021, the 35th Annual Meeting of the Associated Professional Sleep Societies, LLC, which will be held virtually from June 10-13, 2021.

A copy of the poster will be made available on the Zynerba corporate website at the time of presentation at http://zynerba.com/publications/. Additional meeting information can be found on the SLEEP website at https://www.sleepmeeting.org/.

Poster presentation details

Title: Impact of ZYN002 Cannabidiol Transdermal Gel on Sleep in Children and Adolescents with Developmental and Epileptic Encephalopathies and Comorbid Autism Spectrum Disorder
Session: Late-Breaking Abstracts
Date: June 11, 2021
Time: Starting at 12:15 p.m. ET

Zynerba Pharmaceuticals is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.

READ:  Trevena to Present at the JMP Securities Life Sciences Conference

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Notify of
Inline Feedbacks
View all comments